Latest Breaking News On - Meets primary end - Page 1 : comparemela.com

Survival outcomes following curative resection in resectable NSCLC have been poor and, until recently, the main tool oncologists had at their disposal was neoadjuvant or adjuvant chemotherapy.

United statesPerioperative pembrolizumab keytrudaSamuel rosnerNeoadjuvant nivolumab opdivoUniversity of maryland greenebaum comprehensive cancer centerAnnual winter lungMaryland greenebaum comprehensive cancer centerMeets primary endAnnual winter lung cancer conferencePer winter lung cancer conferenceLung cancer